Á lódáil...
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies
BACKGROUND: Molecular markers that can discriminate indolent cancers from aggressive ones may improve the management of prostate cancer and minimize unnecessary treatment. Aberrant DNA methylation is a common epigenetic event in cancers and HOXD3 promoter hypermethylation (H3PH) has been found in pr...
Na minha lista:
Foilsithe in: | Prostate |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
BlackWell Publishing Ltd
2014
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4285328/ https://ncbi.nlm.nih.gov/pubmed/24847526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22790 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|